NSHSF (Nanosphere Health Sciences) OCF Margin %: 0.00% (As of Dec. 2025)


What is Nanosphere Health Sciences OCF Margin %?

Nanosphere Health Sciences NSHSF OCF Margin % is 0.00% as of Dec. 2025. Among 957 Biotechnology companies, Nanosphere Health Sciences ranks worse than 104493.1% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Nanosphere Health Sciences's Cash Flow from Operations for the three months ended in Dec. 2025 was $-0.03 Mil. Nanosphere Health Sciences's Revenue for the three months ended in Dec. 2025 was $0.00 Mil. Therefore, Nanosphere Health Sciences's OCF Margin % for the quarter that ended in Dec. 2025 was 0.00%.

As of today, Nanosphere Health Sciences's current OCF Yield % is -14.08%.

The historical rank and industry rank for Nanosphere Health Sciences's OCF Margin % or its related term are showing as below:


During the past 13 years, the highest OCF Margin % of Nanosphere Health Sciences was -495.47%. The lowest was -8533.33%. And the median was -4514.40%.

NSHSF's OCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -66.52
* Ranked among companies with meaningful OCF Margin % only.

Nanosphere Health Sciences OCF Margin % Related Terms

Nanosphere Health Sciences OCF Margin % Historical Data

* Premium members only.

The historical data trend for Nanosphere Health Sciences's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nanosphere Health Sciences OCF Margin % Chart

Nanosphere Health Sciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Nanosphere Health Sciences Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Nanosphere Health Sciences OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Nanosphere Health Sciences's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-0.023/0
= %

Nanosphere Health Sciences's OCF Margin for the quarter that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-0.032/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Nanosphere Health Sciences (NSHSF) has a OCF Margin % of 0.00% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Nanosphere Health Sciences and its competitors. According to the industry distribution chart, Nanosphere Health Sciences ranks #999999 out of 957 companies in the Biotechnology industry.
Is Nanosphere Health Sciences' OCF Margin % too high?
Nanosphere Health Sciences' current OCF Margin % is 0.00%. Based on the distribution chart, Nanosphere Health Sciences ranks #999999 out of 957 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does Nanosphere Health Sciences' OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Nanosphere Health Sciences ranks #999999 out of 957 companies for OCF Margin %. This places Nanosphere Health Sciences in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Nanosphere Health Sciences and its competitors. Nanosphere Health Sciences's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nanosphere Health Sciences stock overvalued right now?
Nanosphere Health Sciences (NSHSF) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Nanosphere Health Sciences (NSHSF), the current OCF Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nanosphere Health Sciences Business Description

Other Exchanges 2CG:GermanyNSHS:Canada
Address 605 Robson Street, c/o Suite 430, Vancouver, BC, CAN, V6B 5J3
Nanosphere Health Sciences Inc is a biotechnology company focused on providing next generation delivery of biologically active compounds through licensing and joint venture arrangements. The Company has developed and is commercializing its patented NanoSphere Delivery System, a nanotechnology platform for the delivery of biological agents such as cannabinoids, supplements, nutraceuticals, and over-the-counter medications for the cannabis, pharmaceutical, and animal health industries. The NanoSphere Delivery System provides improved bioavailability, efficacy, and onset of effect over traditional delivery systems.